[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kitae et al., 2021 - Google Patents

Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study

Kitae et al., 2021

View PDF
Document ID
14107440006169700633
Author
Kitae A
Ushigome E
Hashimoto Y
Majima S
Senmaru T
Osaka T
Okada H
Hamaguchi M
Asano M
Yamazaki M
Fukui M
Publication year
Publication venue
Journal of Diabetes Investigation

External Links

Snippet

Abstract Aims/Introduction Postprandial hypotension (PPH) refers to a decrease in systolic blood pressure by≥ 20 or to< 90 mmHg from baseline≥ 100 mmHg within 2 h of a meal. Previous studies have reported an association between diabetes and PPH; however, the …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/322Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Similar Documents

Publication Publication Date Title
Jun et al. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
Chen et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients
Raval et al. Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care centre
Ooteman et al. Measuring craving: an attempt to connect subjective craving with cue reactivity
Sekiguchi et al. Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double‐blind placebo‐controlled study in Japan
Ko et al. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with type 2 diabetes mellitus: a 7‐year follow‐up study
Baden et al. Association of adiponectin with blood pressure in healthy people
Menant et al. Pain and anxiety mediate the relationship between dizziness and falls in older people
Chao et al. Binge eating and weight loss outcomes in individuals with type 2 diabetes: 4‐year results from the Look AHEAD Study
Liu et al. Glycaemic control and its associated factors in Chinese adults with type 1 diabetes mellitus
Dybjer et al. Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population‐based study
Jeffery et al. Mood and its association with metabolic health in adolescents: a longitudinal study, EarlyBird 65
Ohashi et al. Diabetes management and daily functioning burden of non‐severe hypoglycemia in Japanese people treated with insulin
Christensen et al. Prevalence of diabetic neuropathy in young adults with type 1 diabetes and the association with insulin pump therapy
Ida et al. Relationship between sarcopenia and depression in older patients with diabetes: An investigation using the Japanese version of SARC‐F
Thomas et al. Ethnicity, perceived discrimination, and vascular reactivity to phenylephrine
Sato et al. Association of visit‐to‐visit glycemic variability with risk of cardiovascular diseases in high‐risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial
Matsuoka et al. Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: a multicenter cross‐sectional study
Abu Sheikh et al. Correlates of treatment satisfaction and well‐being among patients with type II diabetes
Kitae et al. Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study
Logge et al. Executive functioning moderates responses to appetitive cues: a study in severe alcohol use disorder and alcoholic liver disease
Candido Which patients should be evaluated for blood glucose variability?
Davis et al. Association between different hemoglobin A1c levels and clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus
Masheb et al. Sex differences and correlates of pain in patients with comorbid obesity and binge eating disorder
Buxton et al. Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients